Professional Documents
Culture Documents
PMH Social Anxiety Disorder
PMH Social Anxiety Disorder
Anxiety
Disorder
Table of Contents
Social anxiety
Clinical Features
1
disorder
Introduction 4 Here you could
describe the topic of
the section
Course and
Cause
2 Neuro chemical
Genetic
5 Prognosis
Psychological
Environmental
Treatment
3 Criteria
DSM-5 Diagnostic 6 Pharmacotherapy
Psychotherapy
Social Anxiety
disorder
● Social anxiety disorder (also
referred to as social phobia)
involves the fear of social
situations, including situations
that involve scrutiny or
contact with strangers.
● The fear is of potential
embarrassment or negative
evaluation, not the situation
itself
● https://youtu.be/QLjPrNe63kk
?si=ezEos-oZ_CVXEmbz
Causes
Neurochemical Factors
• Efficacy of beta-blockers for performance anxiety
suggests adrenergic system involvement
• Possibly due to excessive norepinephrine/epinephrine
release or sensitivity
• Better response to MAOIs than tricyclics for
generalized social anxiety points to potential
dopaminergic dysfunction
Causes
Genetic Factors
• First-degree relatives of those with social anxiety are 3
times more likely to also have the disorder
• Studies of twins indicate higher concordance rates in
identical (monozygotic) twins compared to fraternal
(dizygotic) twins
• This suggests a genetic vulnerability component to
developing social anxiety disorder
Causes
Psychological factors:
● Negative thought patterns, low self-esteem, and
cognitive biases (e.g., overestimating the likelihood of negative
social events) can play a role in the development and
maintenance of Social Phobia.
Environmental factors
● Traumatic social experiences, such as bullying or humiliation,
during childhood or adolescence, and parenting styles that
promote insecurity or social withdrawal, may increase the risk of
developing Social Phobia.
Some infants exhibit an innate "behaviorally inhibited"
temperament - shyness/withdrawal. This increases risk for later
DSM-5 Diagnostic Criteria